Taiwan Semiconductor
TSM
Advanced Micro Devices
AMD
Alphabet-A
GOOGL
Alphabet-C
GOOG
NVIDIA
NVDA
US Stock MarketDetailed Quotes
TMCI Treace Medical Concepts
- 8.840
- +0.080+0.91%
Close Mar 4 16:00 ET
- 9.170
- +0.330+3.73%
Post 19:09 ET
553.55MMarket Cap-9.82P/E (TTM)
8.940High8.250Low697.61KVolume8.550Open8.760Pre Close6.04MTurnover1.47%Turnover RatioLossP/E (Static)62.62MShares13.26552wk High4.90P/B419.74MFloat Cap3.92052wk Low--Dividend TTM47.48MShs Float37.170Historical High--Div YieldTTM7.88%Amplitude3.920Historical Low8.658Avg Price1Lot Size
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Treace Medical Concepts Stock Forum
Treace Announces First Surgical Cases Utilizing the SpeedPlate™ MicroQuad™ Implant
FREY= SHORTED from $1.90s $2s
BNZI= SHORTED from $3.70s SHORTS 🩳 waiting for $4s one last Spike
ELWS= SHORTED from $8s, $7s first entry SHORT
DYXY= SHORTED from $22s
TMCI= SHORTED from $8s
GNLN= SHORTED from $4s
CIFR= SHORTED from $7s
IHRT= SHORTED from $2.80s
$Invesco QQQ Trust (QQQ.US)$ $AMC Entertainment (AMC.US)$ $GameStop (GME.US)$ $NVIDIA (NVDA.US)$ $SPDR S&P 500 ETF (SPY.US)$
Revenue of $45.1 million in third quarter 2024 increased 11% over same period in 2023
•
Third quarter 2024 net loss was ($15.4) million compared to ($17.5) million for same period in 2023. Adjusted EBITDA loss improved 45% to ($5.1) million in the third quarter 2024 compared to ($9.2) million for the same period in 2023
•
Announces first entry into high volume osteotomy market with Nanoplasty™ 3D Minimally Invasive Bunion ...
No comment yet